サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1079915

医薬品-医療機器コンビネーション製品の世界市場規模：製品別、地域別の予測（2022年～2028年）

Global Drug Device Combination Products Market Size study, byProduct,and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医薬品-医療機器コンビネーション製品の世界市場規模：製品別、地域別の予測（2022年～2028年）
出版日: 2022年05月23日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医薬品-医療機器コンビネーション製品の市場規模は、2021年に約1,180億米ドルとなり、2022年～2028年の予測期間には8.6％以上の健全な成長が見込まれています。

慢性疼痛疾患の高い有病率は、今後数年間、世界の医薬品-医療機器コンビネーション製品市場の成長を促進すると予想されています。また、医療設備の拡大と薬物送達技術の進歩が、予測期間を通じて市場の成長を支えると見込まれています。

当レポートでは、世界の医薬品-医療機器コンビネーション製品市場について調査分析し、市場の概要とともに、製品別・地域別の予測、および競合情報を含む包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の医薬品-医療機器コンビネーション製品市場の定義と範囲

第3章 世界の医薬品-医療機器コンビネーション製品市場力学

  • 医薬品-医療機器コンビネーション製品市場の影響分析（2020-2028）

第4章 世界の医薬品-医療機器コンビネーション製品市場：業界分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • ライバルの脅威
    • ポーターのファイブフォースモデルへの未来的なアプローチ（2018年～2028年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界の医薬品-医療機器コンビネーション製品市場：製品別

  • 市場スナップショット
  • 世界の医薬品-医療機器コンビネーション製品市場：製品別、実績 - 潜在的分析
  • 世界の医薬品-医療機器コンビネーション製品市場の推定と予測：製品別（2018年～2028年）
  • 医薬品デバイスの組み合わせ製品市場：サブセグメント分析
    • 輸液ポンプ
    • 整形外科コンビネーション製品
    • 光線力学的治療機器
    • 経皮吸収パッチ
    • 薬剤溶出ステント
    • 創傷ケア製品
    • 吸入器
    • 抗菌カテーテル
    • その他

第7章 世界の医薬品-医療機器コンビネーション製品市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋　　
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第8章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Abbott
    • Terumo Corporation
    • Stryker Corporation
    • Mylan N.V.
    • Medtronic
    • Allergan plc
    • Boston Scientific Corporation
    • Novartis AG
    • C.R. Bard
    • Teleflex Incorporated

第9章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. GlobalDrug Device Combination Products Market, report scope
  • TABLE 2. GlobalDrug Device Combination Products Market estimates & forecasts by Region2018-2028 (USDBillion)
  • TABLE 3. GlobalDrug Device Combination Products Market estimates & forecasts byProduct2018-2028 (USDBillion)
  • TABLE 4. GlobalDrug Device Combination Products Market by segment, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 5. GlobalDrug Device Combination Products Market by region, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 6. GlobalDrug Device Combination Products Market by segment, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 7. GlobalDrug Device Combination Products Market by region, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 8. GlobalDrug Device Combination Products Market by segment, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 9. GlobalDrug Device Combination Products Market by region, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 10. GlobalDrug Device Combination Products Market by segment, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 11. GlobalDrug Device Combination Products Market by region, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 12. GlobalDrug Device Combination Products Market by segment, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 13. GlobalDrug Device Combination Products Market by region, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 14. U.S.Drug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 15. U.S.Drug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 16. U.S.Drug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 17. CanadaDrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 18. CanadaDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 19. CanadaDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 20. UKDrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 21. UKDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 22. UKDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 23. GermanyDrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 24. GermanyDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 25. GermanyDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 26. RoEDrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 27. RoEDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 28. RoEDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 29. ChinaDrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 30. ChinaDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 31. ChinaDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 32. IndiaDrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 33. IndiaDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 34. IndiaDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 35. JapanDrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 36. JapanDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 37. JapanDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 38. RoAPACDrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 39. RoAPACDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 40. RoAPACDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 41. BrazilDrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 42. BrazilDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 43. BrazilDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 44. MexicoDrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 45. MexicoDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 46. MexicoDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 47. RoLADrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 48. RoLADrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 49. RoLADrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 50. RowDrug Device Combination Products Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 51. RowDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 52. RowDrug Device Combination Products Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 53. List of secondary sources, used in the study of globalDrug Device Combination Products Market
  • TABLE 54. List of primary sources, used in the study of globalDrug Device Combination Products Market
  • TABLE 55. Years considered for the study
  • TABLE 56. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. GlobalDrug Device Combination Products Market, research methodology
  • FIG 2. GlobalDrug Device Combination Products Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. GlobalDrug Device Combination Products Market, key trends 2021
  • FIG 5. GlobalDrug Device Combination Products Market, growth prospects 2022-2028
  • FIG 6. GlobalDrug Device Combination Products Market, porters 5 force model
  • FIG 7. GlobalDrug Device Combination Products Market, pest analysis
  • FIG 8. GlobalDrug Device Combination Products Market, value chain analysis
  • FIG 9. GlobalDrug Device Combination Products Market by segment, 2018 & 2028 (USDBillion)
  • FIG 10. GlobalDrug Device Combination Products Market by segment, 2018 & 2028 (USDBillion)
  • FIG 11. GlobalDrug Device Combination Products Market by segment, 2018 & 2028 (USDBillion)
  • FIG 12. GlobalDrug Device Combination Products Market by segment, 2018 & 2028 (USDBillion)
  • FIG 13. GlobalDrug Device Combination Products Market by segment, 2018 & 2028 (USDBillion)
  • FIG 14. GlobalDrug Device Combination Products Market, regional snapshot 2018 & 2028
  • FIG 15. North AmericaDrug Device Combination Products Market2018 & 2028 (USDBillion)
  • FIG 16. EuropeDrug Device Combination Products Market2018 & 2028 (USDBillion)
  • FIG 17. Asia pacificDrug Device Combination Products Market2018 & 2028 (USDBillion)
  • FIG 18. Latin AmericaDrug Device Combination Products Market2018 & 2028 (USDBillion)
  • FIG 19. GlobalDrug Device Combination Products Market, company Market share analysis (2021)
目次

Global Drug Device Combination Products Market is valued approximately USD 118 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.6% over the forecast period 2022-2028.Drug device combination products are made up of at least two goods, one of which is a medical device and the other of which is a drug, that operate together to treat a patient. The study examines the market for drug-device combinations that are employed in the healthcare sector. A drug device combination product might be a single item or a collection of items packaged separately. The high prevalence of chronic pain conditions is expected to fuel strong growth in the worldwide drug-device combination products market in the coming years. In the coming years, government and non-government measures to stimulate medication delivery implants, as well as an increase in demand for less invasive operations and interventional cardiologists, are expected to boost the market. For instance, according to the National Center for Biotechnology Information, ischemic heart disease affected 126 million people (1,655 per 100,000) in 2017, accounting for 1.72 percent of the global population (NCBI). Furthermore, new advancements and expanded applications of medication device combination products are likely to boost market growth over the forecast period.However, the industry is projected to be hampered by strict regulatory standards, product recalls, and problems associated with particular drug-device combos. Growing healthcare infrastructure and advancements in drug delivery technologies, on the other hand, are likely to support market growth throughout the forecast period.

The key regions considered for the global Drug Device Combination Products Marketstudy includes Asia Pacific, North America, Europe, Latin America, and Rest of the World.In 2021, North America held the dominant share This is due to the considerable new product development operations carried out by major businesses throughout the region. One of the primary prospective growth reasons responsible for the significant clinical urgency to incorporate these items in this region is the expanding chronic disease load. This is thought to contribute to the market's growth in North America. whereas , Asia Pacific is expected to grow at a profitable rate. The significant increase can be attributable to rising healthcare costs. Rising physician awareness of the benefits of these products, such as low dosage requirements, timed medication release, direct device-centered infection mitigation employing anti-infective medications in combination, and lower systemic exposure, all contribute to regional market expansion. High R&D investments by global market participants, as well as rising commercialization of these systems produced by key companies, are driving the market.

Major market player included in this report are:

Abbott

Terumo Corporation

Stryker Corporation

Mylan N.V.

Medtronic

Allergan plc

Boston Scientific Corporation

Novartis AG

C.R. Bard

Teleflex Incorporated

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

ByProduct:

Infusion Pumps

Orthopedic Combination Products

Photodynamic Therapy Devices

Transdermal Patches

Drug Eluting Stents

Wound Care Products

Inhalers

Antimicrobial Catheters

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Drug Device Combination Products Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Drug Device Combination Products Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Drug Device Combination Products Market, by Product,2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. GlobalDrug Device Combination Products Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. GlobalDrug Device Combination Products Market Dynamics

  • 3.1. Drug Device Combination Products Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing demand for minimally invasive drug delivery devices
      • 3.1.1.2. Technological advancements
    • 3.1.2. Market Challenges
      • 3.1.2.1. High associated costs
      • 3.1.2.2. Technical challenges in drug delivery
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing popularity of point of care treatment
      • 3.1.3.2. Consistent interventions by government healthcare organizations

Chapter 4. GlobalDrug Device Combination Products MarketIndustry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. GlobalDrug Device Combination Products Market, by Product

  • 6.1. Market Snapshot
  • 6.2. GlobalDrug Device Combination Products Market by Product, Performance - Potential Analysis
  • 6.3. GlobalDrug Device Combination Products Market Estimates & Forecasts by Product2018-2028 (USD Billion)
  • 6.4. Drug Device Combination Products Market, Sub Segment Analysis
    • 6.4.1. Infusion Pumps
    • 6.4.2. Orthopedic Combination Products
    • 6.4.3. Photodynamic Therapy Devices
    • 6.4.4. Transdermal Patches
    • 6.4.5. Drug Eluting Stents
    • 6.4.6. Wound Care Products
    • 6.4.7. Inhalers
    • 6.4.8. Antimicrobial Catheters
    • 6.4.9. Others

Chapter 7. GlobalDrug Device Combination Products Market, Regional Analysis

  • 7.1. Drug Device Combination Products Market, Regional Market Snapshot
  • 7.2. North AmericaDrug Device Combination Products Market
    • 7.2.1. U.S.Drug Device Combination Products Market
      • 7.2.1.1. Productbreakdown estimates & forecasts, 2018-2028
    • 7.2.2. CanadaDrug Device Combination Products Market
  • 7.3. EuropeDrug Device Combination Products Market Snapshot
    • 7.3.1. U.K.Drug Device Combination Products Market
    • 7.3.2. GermanyDrug Device Combination Products Market
    • 7.3.3. FranceDrug Device Combination Products Market
    • 7.3.4. SpainDrug Device Combination Products Market
    • 7.3.5. ItalyDrug Device Combination Products Market
    • 7.3.6. Rest of EuropeDrug Device Combination Products Market
  • 7.4. Asia-PacificDrug Device Combination Products Market Snapshot
    • 7.4.1. ChinaDrug Device Combination Products Market
    • 7.4.2. IndiaDrug Device Combination Products Market
    • 7.4.3. JapanDrug Device Combination Products Market
    • 7.4.4. AustraliaDrug Device Combination Products Market
    • 7.4.5. South KoreaDrug Device Combination Products Market
    • 7.4.6. Rest of Asia PacificDrug Device Combination Products Market
  • 7.5. Latin AmericaDrug Device Combination Products Market Snapshot
    • 7.5.1. BrazilDrug Device Combination Products Market
    • 7.5.2. MexicoDrug Device Combination Products Market
  • 7.6. Rest of The WorldDrug Device Combination Products Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Abbott
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Terumo Corporation
    • 8.2.3. Stryker Corporation
    • 8.2.4. Mylan N.V.
    • 8.2.5. Medtronic
    • 8.2.6. Allergan plc
    • 8.2.7. Boston Scientific Corporation
    • 8.2.8. Novartis AG
    • 8.2.9. C.R. Bard
    • 8.2.10. Teleflex Incorporated

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption